Hematology History
3rd–5th century CE, Babylonian Talmud (rabbinical legal discussions of circumcision exemptions)
Hemophilia, a hereditary condition in which blood does not clot normally, has left traces in historical records stretching back nearly two millennia, recognized long before any understanding of its genetic or biochemical nature existed. Early physicians and religious scholars observed families in which males were prone to uncontrolled bleeding and attempted to document and accommodate this pattern, though explanations remained rooted in ancient frameworks of humors and vital spirits. The condition's hereditary pattern attracted sustained scientific attention in the 19th century and eventually became central to landmark developments in genetics and the study of blood coagulation.
Historical Narrative
Among the earliest known written references to what is now understood as hemophilia appears in the Babylonian Talmud, compiled between the 3rd and 5th centuries CE, where rabbinical scholars discussed exemptions from circumcision for male children in families where previous male infants had died from uncontrolled bleeding following the procedure. These early legal and religious texts represent a remarkable empirical observation of hereditary bleeding risk across generations, even though no mechanistic explanation was available to the scholars who recorded them.
Medieval Arabic medical literature also engaged with bleeding disorders. The 10th and 11th century Andalusian physician Abu al-Qasim al-Zahrawi, known in European scholarship as Abulcasis, described in his encyclopedic medical text 'Al-Tasrif' the deaths of males within certain families following minor wounds, and noted the pattern of the condition passing through maternal lines to sons — an observation that anticipated by centuries the formal identification of X-linked inheritance. His description is considered one of the most detailed pre-modern accounts of a bleeding disorder consistent with hemophilia.
In European medicine of the medieval and early modern periods, excessive bleeding in certain family lines was attributed to an excess of blood or to corrupted humors that prevented proper coagulation, which physicians of that era understood as a kind of congealing or thickening of blood driven by vital heat. Treatments documented in this era included herbal styptics, application of spider webs, cauterization, and prayers to patron saints — none of which addressed any underlying mechanism, as no such mechanism was yet conceivable within contemporary medical frameworks.
The word 'hemophilia' itself was coined in the early 19th century. The German physician Johann Lukas Schönlein is widely credited with introducing the term around 1828, and his student Friedrich Hopff used it in a published description of the condition in 1828. The American physician John Conrad Otto had earlier produced, in 1803, a detailed and scientifically significant account of a bleeding disorder in a New Hampshire family traceable over three generations, in which he carefully noted that the condition affected only males while passing through females — one of the clearest early published articulations of a sex-linked hereditary pattern in medical literature.
Hemophilia gained extraordinary historical visibility in the 19th century through its presence in the descendants of Britain's Queen Victoria, who is now believed by historians and geneticists to have carried the gene variant. Several of her male descendants across European royal families — in Russia, Spain, and Prussia — were affected, a circumstance that gave the condition the informal historical name 'the royal disease' and drew sustained public and scientific attention to hereditary blood disorders.
The biochemical story of hemophilia began to unfold in the 20th century, when researchers in the 1930s and 1940s identified the specific clotting factors whose absence underlies different forms of the condition. Armand James Quick developed laboratory methods for measuring clotting time in the 1930s, and the distinction between what would become known as hemophilia A and hemophilia B was formally established in the early 1950s, largely through the work of Rosemary Biggs and her colleagues at Oxford.
Key Historical Figures
Historical narrative only — this page describes how Hemophilia was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.